Microbicides 2004HomeAbout the eventSponsors and collaboratorsCommittee membersChair biographiesSatellitesPhotos

Speeches

SatellitesContact

 Microbicides 200428-31 March 2004, Hilton London MetropoleThe conference42 million men, women and children worldwide were living with HIV by the end of December 2002 (source: UNAIDS), including five million newly-infected during that year alone. Another 45 million people will become infected between 2002 and 2010, unless the current transmission rates can be vastly reduced. Of the 42 million, 29.4 million live in sub-Saharan Africa and 58% of them are women. Not only are women more susceptible to HIV infection, many are powerless to insist on the use of condoms or other methods of protecting themselves. In this context, and with the knowledge that an effective HIV vaccine is unlikely to be available for several years, the need for an effective topical microbicide grows ever more urgent. 2004 should prove to be a landmark year in the field of microbicide development as the first Phase III trials of novel products are due to start – the next step along the road to making a microbicide available to the millions worldwide in desperate need of protection.The aims of the Microbicides 2004 conference are to:Report novel or innovative work in the microbicides fieldProvide updates on recent microbicides research, divided into three tracks: basic science, clinical science, and behavioural science (including public health and the microbicide marketplace)Provide a forum for the discussion of new developments in microbicide research including ethical, clinical, behavioural and methodological issuesPresent opportunities for knowledge-sharing between microbicide researchers, public-health workers and advocacy organisations.There will be an opening ceremony on the evening of Sunday 28 March at which politicians, policy makers and the international media are expected. The conference will run for a full three days, each of which will contain:Scientific overviews and presentations with plenary sessions, invited lecturers and presentations of original researchWorkshops to review issues unique to microbicides such as trial design and outcome measures, and ethical issues in the clinical trials of microbicidesPoster sessions. Focus on LondonFollowing the successful Microbicides conferences in Washington in 2000 and Antwerp in 2002, March 2004 sees the focus move to London.The venue is the Hilton Metropole Hotel, two minutes by taxi from Paddington station and the Heathrow Express, with a journey time from the airport of 15 minutes. The hotel is in walking distance of Hyde Park and London’s main shopping streets, and close to Imperial College. Accommodation will be available at the venue and other hotels in the vicinity.London in March offers a variety of diversions for out-of-conference relaxation, including sight-seeing and shopping; the arts and the theatre; and pubs, clubs and restaurants to suit every taste. Conference staff will be on hand to help delegates plan their spare time.To book your place or find out more information, e-mail info@microbicides2004.org.uk or telephone the Event Office on +44 (0) 20 7720 4411
Sunday 28 March Monday 29 March Tuesday 30 March Wednesday 31 March

Tuesday 30 March - key note speeches and plenary presentations

0830-1030 PLENARY SESSION CHAIRED BY GARETH THOMAS MP AND PATRICIA REICHELDERFER

  • Matching mechanisms with microbicides - Robin Shattock (St George's Hospital Medical School, UK)
    Download presentation (powerpoint file)
  • Microbicide prevention and research in the overall context of HIV/STI prevention research - King Holmes (University of Washington, USA)
    Download presentation (powerpoint file)
  • Behavioural measurements: validity and veracity - Basia Zaba (London School of Hygiene and Tropical Medicine, UK)
    Download presentation (powerpoint file)
  • Poster awards

1100-1230 TRACK SESSIONS

  • TRACK A: Matching mechanisms with microbicides
    • John Moore (Cornell University, New York)
      Download presentation (powerpoint file)
    • Preston Marx (Aaron Diamond AIDS Research Center and Tulane University, USA)
      Presentation not available
    • Mark Wainberg (McGill University, Canada)
      Download presentation (powerpoint file)

  • TRACK B: Phase 1 trials, early safety studies
    • Selected short oral presentations (see abstracts)

  • TRACK C: Ethics
    • Informed consent
    • Research communities and clinical trials
    • Sustainability
    • Selected short oral presentations concluding with a panel discussion with Ezekiel Emanuel, Zulfiqar Bhutta, Kathy Shapiro and Anatoli Kamali
      See abstracts

1300-1400 POSTERS

1400-1530 TRACK SESSIONS

  • TRACK A: Microbicides that impact on HIV and/or other STDs
  • TRACK B: Lab tests (emerging issues in rapid tests, measurement of early infection and CD4 counts)
    • Wendy Stevens (National Health Laboratory Service, South Africa)
      Presentation not available
    • Tim Granade (CDC)
      Presentation not available

  • TRACK C: Microbicides and public health
    • Policy, advocacy, constituency building and post-trial introduction
    • Acceptability and user perspectives
    • Health and economic benefits - model projections
    • Selected short oral presentations (see abstracts)

1600-1630 Keynote speech: Stephen Lewis, UN ENVOY, HIV/AIDS IN AFRICA

Download speech (word file)

Stephen Lewis was appointed Special Envoy for HIV/AIDS in Africa by UN Secretary-General Kofi Annan. From 1995 to 1999, he was Deputy Executive Director of UNICEF in New York, having been UNICEF’s Special Representative and acting as a spokesperson for UNICEF’s passionate advocacy of the rights and needs of children, especially children of the developing world. He was formerly Canadian Ambassador to the United Nations, chairing the Committee that drafted the Five-Year UN Programme on African Economic Recovery. He also chaired the first International Conference on Climate Change, which drew up the first comprehensive policy on global warming. Prior to his nomination as Ambassador, Mr. Lewis was a radio and television commentator, and a labour relations arbitrator.

In 2003, he was appointed a Companion of the Order of Canada, Canada’s highest honour for lifetime achievement. The same year, Maclean’s magazine honoured Mr Lewis as their inaugural ‘Canadian of the Year’. The Stephen Lewis Foundation (www.stephenlewisfoundation.org) has been created to help ease the pain of HIV/AIDS in Africa.

1630-1730 CROSS TRACK SESSION

1800-1930 NIH satellite symposium - Microbicides from conception to consumer: mass prodution issues

1900-onwards Conference reception and dinner